38th Annual Meeting of the American Society of Clinical Oncology; 18-21 May 2002; Orlando, Florida, USA
CITATION STYLE
Danson, S., Arance, A., Lorigan, P., Clamp, A., Hodgetts, J., Lomax, L., … Middleton, M. (2002). A randomized study of temozolomide (TMX) alone, with interferon-alpha (TMZ-IFN) or with thalidomide (TMZ-THL) in metastatic malignant melanoma (MMM). Proceedings of the American Society of Clinical Oncology. Retrieved from http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/614/CN-00695614/frame.html NS -
Mendeley helps you to discover research relevant for your work.